FDG-PET AND PET/CT - Part I
暂无分享,去创建一个
[1] A. Alavi,et al. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[2] D. Lilien,et al. Intense FDG activity in peritoneal tuberculosis mimics peritoneal carcinomatosis. , 2007, Clinical nuclear medicine.
[3] A. Alavi,et al. Dual-Time Point FDG PET Imaging in the Evaluation of Pulmonary Nodules With Minimally Increased Metabolic Activity , 2007, Clinical nuclear medicine.
[4] Y Ishida,et al. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. , 2007, The British journal of radiology.
[5] Abass Alavi,et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] R. Wahl,et al. Lymphadenopathy Resulting From Acute Hepatitis C Infection Mimicking Metastatic Breast Carcinoma on FDG PET/CT , 2006, Clinical nuclear medicine.
[7] Abass Alavi,et al. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] A. Alavi,et al. Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging. , 2005, Clinical nuclear medicine.
[9] M. Graham,et al. Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas. , 2005, Seminars in nuclear medicine.
[10] Tsai Yuh-Feng,et al. FDG PET CT features of an intraabdominal gossypiboma. , 2005, Clinical nuclear medicine.
[11] E. Broussard,et al. F-18 FDG PET-CT imaging of a mycotic aneurysm. , 2005, Clinical nuclear medicine.
[12] Q. Le,et al. Positron‐Emission Tomography for Surveillance of Head and Neck Cancer , 2005, The Laryngoscope.
[13] C. Nathan,et al. Unilateral Vocal Cord Paralysis Causes Contralateral False-Positive Positron Emission Tomography Scans of the Larynx , 2005, The Annals of otology, rhinology, and laryngology.
[14] L. Weih,et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer , 2005, Head & neck.
[15] Z. Gülbaş,et al. Intense F-18 FDG accumulation in stomach in a patient with Hodgkin lymphoma: Helicobacter pylori infection as a pitfall in oncologic diagnosis with F-18 FDG PET imaging. , 2005, Clinical nuclear medicine.
[16] F. Atkins,et al. Reduction of Brown Fat 2-Deoxy-2-[F-18]fluoro-d-glucose Uptake by Controlling Environmental Temperature Prior to Positron Emission Tomography Scan , 2005, Molecular Imaging and Biology.
[17] E. Kramer,et al. Spectrum of thymic uptake at 18F-FDG PET. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[18] J. Thie. Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] A. Alavi,et al. Iatrogenic Artifacts on Whole-Body F-18 FDG PET Imaging , 2004, Clinical nuclear medicine.
[20] R. Wahl,et al. Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] G. V. von Schulthess,et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. , 2004, Archives of otolaryngology--head & neck surgery.
[22] J. Talbot,et al. Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG‐PET , 2003, BJOG : an international journal of obstetrics and gynaecology.
[23] Mithat Gonen,et al. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] W. Oyen,et al. FDG-PET in infectious and inflammatory disease , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[25] Richard L Wahl,et al. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] A. Lammertsma,et al. The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[27] M. Lobrano,et al. Positron emission tomography in oncology. , 2003, Clinical journal of oncology nursing.
[28] Val J Lowe,et al. Clinical 18F-FDG oncology patient preparation techniques. , 2003, Journal of nuclear medicine technology.
[29] Richard L Wahl,et al. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] Thomas F Hany,et al. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. , 2002, AJR. American journal of roentgenology.
[31] Abass Alavi,et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] R. D'Agostino,et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer , 2001, Head & neck.
[33] D. Binns,et al. Pattern of uptake and excretion of (18)F-FDG in the lactating breast. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] U. Cremerius,et al. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma , 2001, Nuklearmedizin.
[35] C. Meltzer,et al. Superphysiologic FDG Uptake in the Non-Paralyzed Vocal Cord. Resolution of a False-Positive PET Result with Combined PET-CT Imaging. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[36] Michael N. Maisey,et al. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine , 1999, European Journal of Nuclear Medicine.
[37] H. Herzog,et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer , 1999, European Journal of Nuclear Medicine.
[38] R L Wahl,et al. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[39] S. Yasuda,et al. Lactating breast exhibiting high F-18 FDG uptake. , 1998, Clinical nuclear medicine.
[40] A. Ezzat,et al. F-18-FDG uptake in tuberculosis. , 1998, Clinical nuclear medicine.
[41] D Delbeke,et al. Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] S. Barrington,et al. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] A. Civelek,et al. Bone scintigraphy of caudal regression syndrome. , 1996, Clinical nuclear medicine.
[44] I. Fogelman,et al. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. , 1996, Seminars in nuclear medicine.
[45] A. Buck,et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] R. Wahl. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] J. Keyes. SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[48] K. McGowan,et al. Glucose transporter gene expression: regulation of transcription and mRNA stability. , 1995, Pharmacology & therapeutics.
[49] L M Hamberg,et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[50] S. Cherry,et al. Physics in Nuclear Medicine , 2004 .
[51] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[52] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.